The increasing popularity of fertility trackers and other women-focused tech has spurred the growth of reproductive health companies with a digital focus. For example, Natural Cycles, the first birth control app to be CE-certified as a contraceptive in Europe, raised $30M in Series B funding back in 2017. Ava, maker of an ovulation tracking bracelet, also raised $30M in Series B funding early last year. NextGen Jane, a startup seeking to make it within the increasingly competitive reproductive health space, closed a $9M Series A funding round earlier this week. Leading the round was Material Impact. Additional investors include Access Industries, Viking Global Investors, and Liminal Ventures. NextGen Jane is planning to mail kits to women with a tampon they can send back and have analyzed. The Oakland, California-based startup will use the influx of cash to further its scientific dataset and prepare for a 2020 product launch. By providing women with accessible methods to understanding their reproductive health, NextGen Jane and other femtech startups will only continue to grow in the coming years.